Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC 17:0_22:4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004421 AN007397 Comparative lipidomics of iPSC-derived microglia protocols reveal lipid droplet and immune differences mediated by media composition Human iPSC Human Alzheimers disease VU Amsterdam MS(Dir. Inf.)
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST003410 AN005599 Lipidomics Analysis of ER+ Breast Cancer Cells Treated with Giredestrant and Palbociclib Cultured cells Human Cancer Genentech Inc. LC-MS
ST003409 AN005596 Impact of giredestrant on the lipid profile of MCF-7 breast cancer cells Cultured cells Human Cancer Genentech Inc. LC-MS
ST003108 AN005090 Complete absence of GLUT1 does not impair human terminal erythroid differentiation Cultured cells Human GLUT1 Deficiency Syndrome University of Colorado LC-MS
ST002522 AN004156 Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice Liver Mouse Oxidative stress University of Science and Technology of China LC-MS
ST001267 AN002104 Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism Tongue Human Cancer University of Helsinki MS(Dir. Inf.)
  logo